Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.42 -0.10 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) EV to EBIT (2025 - 2026)

Updated

Aurinia Pharmaceuticals' EV to EBIT was 12.02 in Q2 2026, down 22.7% from 15.55 a year earlier and down 4.0% from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) EV to EBIT (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aurinia Pharmaceuticals' EV to EBIT was 4.54 through Jun 30, 2026; for FY2025, it was 16.32.

  • Per Business Quant data, AUPH's EV to EBIT in the three quarters before Q2 2026 was 12.53 (Q1 2026), 16.32 (Q4 2025) and 15.78 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Aurinia Pharmaceuticals 2.20 Bn 623.91 Mn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.02
Mar 31, 2026 12.53
Dec 31, 2025 16.32
Sep 30, 2025 15.78
Jun 30, 2025 15.55
Mar 31, 2025 26.13
API Access

Aurinia Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AUPH&period=max&api_key=YOUR_API_KEY